Apotex, Orbicular & Gland Pharma Secure Dual ANDA...
Category : Approval/Launch 17 April 2026In a market where complexity often deters competition, three companies have just executed a near tex...
Approval Launch
GSK Expands Exdensur’s Reach in China: A New Optio...
Category : Approval/Launch 10 April 2026Global biopharma leader GSK plc has secured another regulatory win in China. China’s Nation...
Cipla Expands U.S. Respiratory Portfolio with Appr...
Category : Approval/Launch 3 April 2026Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087) (NSE: CIPLA) (hereafter ref...
GSK Scores a First: FDA Approves Lynavoy for Chron...
Category : Approval/Launch 23 March 2026Some conditions are overlooked—not because they’re rare, but because they’re misun...
European Commission Approves Lupin’s Biosimilar Ra...
Category : Approval/Launch 24 February 2026Lupin Limited has received approval from the European Commission for its biosimilar ranibizumab, Ran...
Latest Newsletter Post
-
Nektar Therapeutics to Unveil 52-We..
20 April 2026
-
Beyond Headaches: New INFUSE Study..
20 April 2026
-
Apotex, Orbicular & Gland Pharma Se..
17 April 2026
-
Brenig Therapeutics Heads to AAN 20..
17 April 2026
-
A New Window Into Parkinson’s Disea..
16 April 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com